Deliver Care

Patient Selection & Support Resources

Ensuring CAR-T is a match for your patient is a clinical, financial and logistical decision made together. This page sets out the criteria community programs weigh, and the resources that help patients and care partners get through treatment.

Key Selection Criteria

Community programs that select patients well share a common structure: a standing multidisciplinary committee that reviews every candidate against clinical, financial and logistical criteria before workup begins. Thresholds vary by center, by physician and by product.

Indication-Specific Eligibility — Confirm the patient’s disease type, line of therapy and product label indication first, then complete the baseline laboratory studies and imaging your protocol requires before workup proceeds
Additional Clinical Factors — Comorbidities, organ function, such as renal, cardiac and pulmonary, and disease characteristics complete the clinical picture. Product toxicity profile and time to CRS and ICANS onset also inform the patient treatment plan.
Care Partner Availability — A dedicated care partner who can give 24-hour support during outpatient phases, transport the patient, help manage medications and recognize when to call the team. Creative solutions exist when one dedicated partner is not an option.
Proximity and Logistics — Ability to commit to remaining in proximity to a healthcare facility for up to two weeks after infusion and to avoid driving for two weeks. Centers set their own radius.

Patient & Caregiver Support Resources

Clinical eligibility is only part of the decision. Lodging near the center, insurance navigation and a care partner who can be present around the clock all affect whether a patient can complete treatment. Example support organizations below, but there are many available resources including organizations in or near your community. Product manufacturers also run their own support programs.

Education: Cancer Support Community

Cancer Support Community provides helpful information on CAR-T treatments and support services

Education: American Cancer Society

American Cancer Society provides insights on the CAR-T treatment process and considerations

Care Partner: BMT InfoNet

Care Partners are critical in the journey for CAR-T treatment. BMT InfoNet provides an outline of responsibilities and resources

Financial: Patient Advocate Foundation

The Patient Advocate Foundation’s resources can help navigate some of the financial needs a patient may face. The link brings you directly to their National Financial Resource Directory

Support: Lymphoma Research Foundation

The Lymphoma Research Foundation has a Lymphoma Resource Center which has consolidated support services for patients with Lymphoma or CLL

Support: Leukemia Research Foundation

The Leukemia Research Foundation has consolidated patient and family support services for patients with Leukemia

Housing: Joe’s House

Joe’s House is a non profit that works with lodging/accomodations to identify medical discounts. The resources page linked here also includes some transportation assistance

Therapy & Care Delivery Partners

Manufacturers and Delivery partners offer many support options to lessen the burden on patients and caregivers during CAR-T treatment. *Ask your Partners what they have for support services*

Back to Playbook Overview

Next in the Playbook

Guidance for CAR-T Adverse Events

Patient monitoring, after-hour considerations, admissions and emergency partners

Explore

Reimbursement, Billing & Coding

Coding, payment mechanics and the questions payers ask before covering CAR-T at a community site.

Explore

Continuity & Shared Care

Divide work with referral partners, shared care models, the return handoff, and who owns long-term follow-up.

Explore

Not sure where to start?

We’re here to help. Reach out today to connect with experts that can guide you.